Your browser doesn't support javascript.
loading
Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies.
Xu, Yidan; Zhu, Huiqiu; Li, Weiwei; Chen, Danxia; Xu, Ying; Xu, Aimin; Ye, Dewei.
Affiliation
  • Xu Y; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China; Key Laboratory of Metabo
  • Zhu H; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China; Key Laboratory of Metabo
  • Li W; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China; Key Laboratory of Metabo
  • Chen D; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China; Key Laboratory of Metabo
  • Xu Y; School of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
  • Xu A; State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China; Department of Medicine, The University of Hong Kong, Hong Kong, China. Electronic address: amxu@hku.hk.
  • Ye D; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China; Key Laboratory of Metabo
Pharmacol Ther ; 240: 108284, 2022 12.
Article in En | MEDLINE | ID: mdl-36162728
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycystic Ovary Syndrome / Insulin Resistance / Metabolic Syndrome / Diabetes Mellitus, Type 2 / Metabolic Diseases Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Pharmacol Ther Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycystic Ovary Syndrome / Insulin Resistance / Metabolic Syndrome / Diabetes Mellitus, Type 2 / Metabolic Diseases Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Pharmacol Ther Year: 2022 Document type: Article